logo

Rhythm Pharmaceuticals, Inc. (RYTM)



Trade RYTM now with
  Date
  Headline
7/22/2022 8:42:20 AM Rhythm Pharma Gets Positive CHMP Opinion For IMCIVREE
7/18/2022 6:14:33 AM NICE Recommends Rhythm's IMCIVREE For Treating Obesity And Controlling Hunger
7/12/2022 7:14:50 AM Rhythm Pharma Announces Positive Interim Results From Phase 2 Trial Of Setmelanotide In Hypothalamic Obesity
9/20/2021 7:40:57 AM Rhythm Pharma Completes IMCIVREE SNDA Submission For Obesity & Control Of Hunger In Bardet-Biedl And Alström Syndromes
3/20/2021 11:34:49 AM Rhythm Pharmas Presents New Data From Phase 2 Basket Study In Patients With HET Obesity On Setmelanotide At ENDO 2021
1/5/2021 8:20:43 AM Rhythm Enters Definitive Agreement To Sell Its Rare Pediatric Disease PRV For $100 Mln